Algen Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
- Revenue Growth -65.41%
- Profit Growth -196.43%
- Ebitda 306.52%
- Net Worth -4.75%
- Total Assets -90.08%
About Algen Pharma
Algen Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2007 and has a history of 17 years and ten months. Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.50 Cr.
Vamsi Kosuri and Varalakshmi Sama serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232AP2007PTC053369
-
Company No.
053369
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Mar 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Algen Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vamsi Kosuri
|
Director | 28-Mar-2007 | Current |
|
Varalakshmi Sama
|
Director | 18-Apr-2019 | Current |
Financial Performance of Algen Pharma.
Algen Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 65.41% decrease. The company also saw a substantial fall in profitability, with a 196.43% decrease in profit. The company's net worth dipped by a decrease of 4.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Algen Pharma?
In 2019, Algen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Ing Vysya Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jul 2007 | Ing Vysya Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Algen Pharma?
Unlock and access historical data on people associated with Algen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Algen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Algen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
